The cover photo shows a dry powder inhaler with a hypromellose-origin capsule, specifically developed for inhaled drug delivery. Courtesy of Qualicaps®, Avenida Monte Valdelatas, 4, 28108 Madrid, Spain. Tel: +34 916 630 800, www.qualicaps.com
Vo l u m e 1 7 N u m b e r 1 Fe b r u a ry 2 0 2 3
Inhalation
CLICK HERE
TO RENEW TODAY!
Application of biological
models to inform research
and development of
inhalation products
Excipient enhanced growth
(EEG): Expanding delivery
options for treatment
of lung diseases
Cross-industry organizations:
An update from ISAM
Back pages: Slow adoption
for peanut allergy drug and
A food allergy bravery clinic
Previewing RDD®
Europe 2023